Business Context and Reporting Period
This Form 8-K was filed by pSivida Corp. (not Eyepoint, Inc.) on August 1, 2012. The report details a corporate event regarding a private placement of equity securities.
Key Financial Metrics
The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, or existing debt levels. The primary financial data relates to the proposed capital raise:
- Gross Proceeds: Approximately $5.36 million.
- Common Stock Offered: 2,494,419 shares.
- Warrants Offered: Warrants to purchase 623,605 shares of common stock.
- Warrant Terms: Exercise price of $2.50 per share; exercisable for 0.25 of a share; exercisable period begins six months after issuance and ends five years after issuance.
Material Changes
The material change reported is the entry into a placement agent agreement with Rodman & Renshaw, LLC to facilitate the offering of common stock and warrants to institutional investors. This represents a significant potential increase in the company's cash liquidity upon closing.
Guidance, Outlook, and Risks
Outlook and Closing: The offering is expected to close on or about August 7, 2012, subject to customary closing conditions. The transaction is being made pursuant to a prospectus supplement filed in connection with a shelf takedown from a Form S-3 registration statement effective January 7, 2010.
Risks and Contingencies: The closing is contingent upon customary conditions. The filing notes that descriptions of the agreements are qualified by reference to the attached exhibits.
Investor Verification Checklist
- Verify the final closing date of the offering (expected August 7, 2012).
- Confirm the actual gross proceeds received versus the approximate $5.36 million target.
- Review the attached Securities Purchase Agreement (Exhibit 99.1) for specific investor rights and covenants.
- Check the press release issued on August 2, 2012 (Exhibit 99.2) for pricing details and investor composition.
- Monitor future filings for the impact of the new shares and warrants on total outstanding share count and potential dilution.